Skip to content
TRENDING:
Donald Trump
Advertisement

Articles by Tom Howell Jr.

A vial of the Pfizer-BioNTech COVID-19 vaccine at the Royal Victoria Hospital, in Belfast, Tuesday, Dec. 8, 2020. The United Kingdom, one of the countries hardest hit by the coronavirus, is beginning its vaccination campaign, a key step toward eventually ending the pandemic. (Liam McBurney/Pool via AP)

FDA approves Pfizer coronavirus vaccine for emergency use

The Food and Drug Administration approved Pfizer's coronavirus vaccine for emergency use late Friday, launching an historic campaign to inoculate millions of Americans against a disease that's upended normal life, pummeled the economy and killed nearly 300,000 in the U.S.

December 11, 2020
In this file photo dated Wednesday, July 22, 2020, a Pfizer sign is seen on a podium at the Pfizer Research & Development Laboratories, in Groton, Conn. (AP Photo/Stew Milne) **FILE**

Key FDA panel debates Pfizer vaccine

A government advisory panel is debating Pfizer's coronavirus vaccine Thursday and will decide whether its benefits outweigh any risks, clearing a path for the Food and Drug Administration to grant emergency approval so that states can begin to inoculate health workers and nursing-home residents.

December 10, 2020
A nurse holds a vial of the Pfizer-BioNTech COVID-19 vaccine at Guy's Hospital in London, Tuesday, Dec. 8, 2020, as the U.K. health authorities rolled out a national mass vaccination program. (AP Photo/Frank Augstein, Pool)

Operation Warp Speed: We won’t fiddle with Pfizer dosing plan

Leaders of Operation Warp Speed said Wednesday they will not abandon plans to reserve half of the available Pfizer doses when the coronavirus vaccine campaign launches in the coming days, even though new data showed a level of protection after the first shot of the two-dose regimen.

December 9, 2020
In this Oct. 10, 2020, photo, President Donald Trump speaks from the Blue Room Balcony of the White House to a crowd of supporters in Washington. (AP Photo/Alex Brandon) ** FILE **

Trump taunts doubters, citing speed of vaccine

President Trump declared victory over naysayers Tuesday, saying he sped multiple COVID-19 vaccines through the pipeline in a single year, while nudging the Food and Drug Administration to approve Pfizer's version this week.

December 8, 2020
In this file photo, Paula McMahon prepares a shot of the Pfizer-BioNTech COVID-19 vaccine, as the mass public vaccination program gets underway, at the NHS Louisa Jordan Hospital in Glasgow, Scotland, Tuesday Dec. 8, 2020. On Dec. 8, 2020, the FDA released a 53-page briefing document with findings showing the vaccine is effective after the first dose. (Jeff J Mitchell/Pool via AP)

Pfizer vaccine offers protection after the first dose: FDA

The Food and Drug Administration said data from Pfizer shows its vaccine reduced the risk of COVID-19 after the first dose and was "consistent" with regulators' recommendations for emergency approval, signaling a promising start to a review that will unfold this week and likely kickstart the U.S. immunization campaign.

December 8, 2020
Vice President Mike Pence, left, and Centers for Disease Control and Prevention director Dr. Robert Redfield exchange elbow bumps after a briefing at the CDC Friday, Dec. 4, 2020, in Atlanta. (AP Photo/John Bazemore)

Mike Pence: ‘We cut no corners’ on COVID-19 vaccine

A coronavirus vaccine is arriving at record speed but that doesn't mean it will be less safe or effective than other shots, Vice President Mike Pence said Friday, using a tour of the Centers of Disease Control and Prevention in Atlanta to build confidence in an immunization campaign that "may be a week and a half away."

December 4, 2020
Dr. Anthony Fauci, Director of the National Institute of Allergy and Infectious Diseases at the National Institutes of Health, listens during a Senate Senate Health, Education, Labor, and Pensions Committee Hearing on the federal government response to COVID-19 Capitol Hill on Wednesday, Sept. 23, 2020, in Washington. (Graeme Jennings/Pool via AP) ** FILE **

Dr. Anthony Fauci: Joe Biden mask request may go beyond 100 days

Dr. Anthony Fauci said Friday that Americans might need to wear masks beyond the 100-day commitment that presumptive President-elect Joseph R. Biden will outline at his inauguration but that it's still a good idea to make the defined request.

December 4, 2020
In this Nov. 6, 2020, file photo, Certified Nursing Assistant Angelica Corral constantly changes her personal protective equipment (PPE) as she travels from room to room at the El Paso Long Term Acute Care hospital in central El Paso, Texas. U.S. hospitals slammed with COVID-19 patients are trying to lure nurses and doctors out of retirement and recruiting nursing students and new graduates who have yet to earn their licenses. (Mark Lambie/The El Paso Times via AP, File)

U.S. hits 100K hospitalizations for the coronavirus

U.S. hospitalizations for COVID-19 reached 100,000 for the first time and the nation hit an all-time high for deaths in a single day, according to new figures that show the country is paying the price for widespread transmission.

December 3, 2020
This May 4, 2020, file photo provided by the University of Maryland School of Medicine, shows the first patient enrolled in Pfizer's COVID-19 coronavirus vaccine clinical trial at the University of Maryland School of Medicine in Baltimore. Pfizer and BioNTech say they've won permission Wednesday, Dec. 2, 2020, for emergency use of their COVID-19 vaccine in Britain, the world’s first coronavirus shot that’s backed by rigorous science -- and a major step toward eventually ending the pandemic. (Courtesy of University of Maryland School of Medicine via AP, File)

U.S. sticks to timeline after U.K. vaccine approval

The Trump administration said Wednesday it expects two coronavirus vaccines to be approved before Christmas but isn't moving up its deadlines after British regulators beat the Americans to the punch by approving Pfizer's version first.

December 2, 2020